Acute renal failure in hospitalized patients: Part II

Annals of Pharmacotherapy

Volumn 36, Issue 9, 2002, Pages 1430-1442

  Pruchnicki, Maria C ^a   Dasta, Joseph F ^a   Martinez, Mirza D ^a   Dion, Pierre ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acute renal failure

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ACICLOVIR; ALLOPURINOL; AMINOPHYLLINE; AMPHOTERICIN B; ANARITIDE; ANTIOXIDANT; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; DOPEXAMINE; FENOLDOPAM; FUROSEMIDE; HYPERTENSIVE FACTOR; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; ISRADIPINE; LOOP DIURETIC AGENT; MANNITOL; NITRENDIPINE; PARACETAMOL; PROSTAGLANDIN; SODIUM CHLORIDE; SOMATOMEDIN; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ARTICLE; CLINICAL TRIAL; CREATININE CLEARANCE; DIURESIS; DRUG EFFICACY; DRUG INDICATION; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART OUTPUT; HEART STROKE VOLUME; HEART SURGERY; HEMODYNAMIC MONITORING; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MEDLINE; OSMOTIC DIURESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; TREATMENT OUTCOME; URINE VOLUME; CHEMICALLY INDUCED DISORDER; CONGESTIVE HEART FAILURE; HOSPITALIZATION; REVIEW;

HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION;

EID: 0036707924     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A340     Document Type: Article

References (101)

1. Acute renal failure in the new millennium: Time to consider combination therapy
2. Mechanisms of cellular injury in ischemic acute renal failure
3. Acute renal failure: Definition and pathogenesis
4. Acute renal failure: Controversies, clinical trials, and future directions
5. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis
6. Perioperative renal protection
7. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation
8. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients
9. Nutrition in acute renal failure
10. Stress metabolism and nutritional support in acute renal failure
11. Outcome studies of continuous renal replacement therapy in the intensive care unit
12. Acute renal failure in the 21st century: Recommendations for management and outcomes assessment
13. Dopamine increases renal medullary blood flow without improving regional hypoxia
14. Determinants of intrarenal oxygenation. II. Hemodynamic effects
15. Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney
16. The effect of mannitol on reperfusion injury and postischaemic compartment pressure in skeletal muscle
17. Dopamine clearance in critically ill patients
18. The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline
19. Hypoxia of the renal medulla - Its implications for disease
20. The use of diuretics and dopamine in acute renal failure: A systematic review of the evidence
21. Use of dopamine in acute renal failure: A meta-analysis
22. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure
23. Low-dose "renal" dopamine
24. Potential of dopamine A-1 agonists in the management of acute renal failure
25. Effect of postoperative intravenous loop diuretic on renal function after major surgery
26. Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function
27. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: Assessed by measuring retinol binding protein (RBP)
28. Randomized controlled trial of the effect of mannitol on renal reperfusion injury during aortic aneurysm surgery
29. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery
30. 2 adrenergic and dopaminergic agonist: Haemodynamic effects following cardiac surgery
31. Perioperative acute renal failure
32. Effect of dopexamine hydrochloride on renal vascular resistance index and haemodynamic responses following coronary artery bypass graft surgery
33. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status
34. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
35. The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs
36. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs
37. Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repair
38. Renal protection and improved outcome by utilization of a DA-1 agonist (fenoldopam) in TAAA repair
39. Fenoldopam maintains hemodynamic stability in patients undergoing cross-clamping of the abdominal aorta
40. New pharmacologic options for renal preservation
41. Effect of felodipine on renal function and vasoactive hormones in infrarenal aortic surgery
42. Nifedipine can preserve renal function in patients undergoing aortic surgery with infrarenal crossclamping
43. Renal function during cardiopulmonary bypass: Influence of the calcium entry blocker felodipine
44. Intravenous diltiazem and acute renal failure after cardiac operations
45. Effects of human atrial natriuretic peptide in patients after coronary artery bypass surgery
46. Potential role of growth factors in the prophylaxis and treatment of acute renal failure
47. Insulin-like growth factor I preserves renal function postoperatively
48. A pilot study to investigate the effects of an infusion of aminophylline on renal function following major abdominal surgery
49. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation
50. A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthoptic liver transplantation
51. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients
52. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies
53. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation
54. Renal effects of amlodipine in normotensive renal transplant recipients
55. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients
56. Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: A double-blind, randomized, placebo-controlled, multi-center study
57. Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: A randomized trial
58. Hypertension after liver transplantation: A predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations
59. Urodilatin: A new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients
60. Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: A randomized placebo-controlled study
61. 1) does not improve renal function in hepatic transplant recipients
62. 1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial
63. Drug-induced nephrotoxicity
64. Acute renal failure
65. Contrast medium-induced nephrotoxicity: Pathophysiology and prevention
66. Radiocontrast nephropathy: The dye is not cast
67. The effect of acute renal failure on mortality. A cohort analysis
68. Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: A case series
69. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: A pilot trial in the prevention of contrast nephropathy
70. Radiocontrast medium-induced declines in renal function: A role for oxygen free radicals
71. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
72. Acetylcysteine and nephrotoxic effects of radiographic contrast agents - A new use for an old drug
73. Oliguria in the ICU. Systematic approach to diagnosis and treatment
74. Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo-controlled, randomized study
75. Protocol-guided diuretic management: Comparison of furosemide by continuous infusion and intermittent bolus
76. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery
77. More patients with acute renal failure requiring hemodialysis and receiving high dose furosemide reach early two liter diuresis than patients on placebo and may have shorter hemodialysis period
78. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients
79. Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial
80. Is renal dose dopamine protective or therapeutic? No
81. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide)
82. Anaritide in acute tubular necrosis
83. Atrial natriuretic factor in oliguric acute renal failure
84. Therapeutic use of the natriuretic peptide ularitide in acute renal failure
85. Beneficial effect of intrarenal verapamil in human acute renal failure
86. Intrarenal infusion of gallopamil in acute renal failure. A preliminary report
87. Effects of IGF-I on renal function in end-stage chronic renal failure
88. A trial of insulin-like growth factor in postischemic acute renal failure in humans
89. Efficacy and safety of recombinant human activated protein C for severe sepsis
90. Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive care
91. Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria
92. Prolonged low-dose dopamine infusion induces a transient improvement in renal function in hemodynamically stable, critically ill patients: A single-blind, prospective, controlled study
93. Intraplatelet calcium levels in patients with acute renal failure before and after the administration of loop diuretics
94. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers
95. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines
96. Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients
97. Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock
98. Atrial natriuretic peptide as a preload depressor in acute renal failure secondary to congestive heart failure
99. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
100. Low-dose dopamine in the intensive care unit: DNR or DNRx?
101. Fenoldopam - A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension